ArticleCureus2026
Secondary Acrodermatitis Enteropathica in a Premature Low-Birth-Weight Infant: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acrodermatitis enteropathica (AE) is a rare disorder of zinc deficiency that can be hereditary or acquired. Secondary AE is uncommon in premature infants and may mimic other inflammatory or infectious dermatoses, making early diagnosis challenging. A four-month-old premature Egyptian female infant, born at 27 weeks' gestation with a birth weight of 880 g, presented with a one-month history of progressive periorificial and acral dermatitis associated with intermittent diarrhea. The lesions failed to respond to multiple courses of antibiotics. Histopathological findings, together with the clinical presentation and low zinc levels, supported the diagnosis of secondary AE. Oral zinc supplementation resulted in marked clinical improvement. This case highlights the importance of considering secondary AE in premature, low-birth-weight infants presenting with characteristic dermatitis. Early recognition and timely zinc supplementation are essential to prevent complications and achieve favorable clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.